Systems of care for ST-elevation myocardial infarction in India

Heart

Volumn 98, Issue 1, 2012, Pages 15-17

  Alexander, Thomas ^a   Mehta, Sameer ^b   Mullasari, Ajit ^c   Nallamothu, Brahmajee K ^d,e  

^a Kovai Medical Centre and Hospital   (India)

^b UNIVERSITY OF MIAMI   (United States)

^c MADRAS MEDICAL MISSION HOSPITAL   (India)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^e UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL; FIBRINOLYTIC AGENT; RETEPLASE; TENECTEPLASE;

AMBULANCE; CORONARY STENT; DRUG APPROVAL; EARLY INTERVENTION; EMERGENCY HEALTH SERVICE; HEALTH CARE AVAILABILITY; HEALTH CARE DELIVERY; HEALTH CARE FINANCING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEART MUSCLE REPERFUSION; HUMAN; INDIA; PATIENT CARE; PATIENT TRANSPORT; PERCUTANEOUS CORONARY INTERVENTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SOCIAL INSURANCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; EMERGENCY MEDICAL SERVICES; HUMANS; INDIA; INSURANCE, HEALTH; INTERPROFESSIONAL RELATIONS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; QUALITY OF HEALTH CARE; THROMBOLYTIC THERAPY;

EID: 84155165088     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2011-301009     Document Type: Review

References (24)

1. National Commission on Macroeconomics and Health. Burden of Disease in India. Delhi, India: Ministry of Health and Family Welfare, Government of India, 2005. http://www.who.int/macrohealth/action/NCMH-Burden%20of%20disease- (29%20Sep%202005).pdf (accessed 20 Jul 2011).
2. Boersma E, Maas AC, Deckers JW, et al. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-5. (Pubitemid 26308479)
3. Nallamothu BK, Bradley EH, Krumholz HM. Time to treatment in primary percutaneous coronary intervention. N Engl J Med 2007;357:1631-8.
4. Reddy KS. India wakes up to the threat of cardiovascular diseases. J Am Coll Cardiol 2007;50:1370-2. (Pubitemid 47446090)
5. Patel V, Chatterji S, Chisholm D, et al. Chronic diseases and injuries in India. Lancet 2011;377:413-28.
6. Wood A, Pell J, Patel A, et al. Prevention of cardiovascular disease in a rural region of India and strategies to address the unmet need. Heart 2011;97:1373-8.
7. Jacobs AK. Regional systems of care for patients with ST-elevation myocardial infarction: being at the right place at the right time. Circulation 2007;116:689-92. (Pubitemid 47255984)
8. Saia F, Marrozzini C, Ortolani P, et al. Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality. Heart 2009;95:370-6.
9. Revised Poverty Estimates: What does this mean for India? http://www.worldbank.org.in/WBSITE/EXTERNAL/COUNTRIES/SOUTHASIAEXT/INDIAEXTN/0, contentMDK: 21880804~pagePK:141137~piPK:141127~theSitePK:295584,00.html (accessed 20 Jul 2011).
10. Ghaffar A, Reddy KS, Singhi M. Burden of non-communicable diseases in South Asia. BMJ 2004;328:807-10. (Pubitemid 38446379)
11. Leeder S, Raymond S, Greenberg H, et al. A Race Against Time: The Challenge of Cardiovascular Disease in Developing Economies. New York, USA: Columbia University, 2004. http://www.earthinstitute.columbia.edu/news/2004/ images/raceagainsttime-FINAL-051104.pdf (accessed 20 Jul 2011).
12. Jeemon P, Reddy KS. Social determinants of cardiovascular disease outcomes in Indians. Indian J Med Res 2010;132:617-22.
13. Gillman MW. Developmental origins of health and disease. N Engl J Med 2005;353:1848-50. (Pubitemid 41549898)
14. Rani M, Bonu S, Jha P, et al. Tobacco use in India: prevalence and predictors of smoking and chewing in a national cross sectional household survey. Tob Control 2003;12:e4.
15. Ramaraj R, Alpert JS. Indian poverty and cardiovascular disease. Am J Cardiol 2008;102:102-6.
16. Xavier D, Pais P, Devereaux PJ, et al. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet 2008;371:1435-42. (Pubitemid 351601890)
17. Peterson ED, Roe MT, Chen AY, et al. The NCDR ACTION Registry - GWTG: transforming contemporary acute myocardial infarction clinical care. Heart 2010;96:1798-802.
18. Herrett E, Smeeth L, Walker L, et al. The myocardial ischaemia national audit project (MINAP). Heart 2010;96:1264-7.
19. Kumar AKS, Chen LC, Choudhury M, et al. Financing health care for all: challenges and opportunities. Lancet 2011;377:668-79.
20. Armstrong PW, Collen D, Antman E. Fibrinolysis for acute myocardial infarction. Circulation 2003;107:2533-7.
21. Sabatine MS, Cannon CP, Gibson CM, et al. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation. N Engl J Med 2005;352:1179-89. (Pubitemid 40397259)
22. Antman EM, Van de Werf F. Pharmacoinvasive therapy. Circulation 2004;109:2480-6.
23. Reddy KS, Patel V, Jha P, et al. Towards achievement of universal health care in India by 2020: a call to action. Lancet 2011;377:760-8.
24. Mallipedi R, Pernefeldt H, Bergkvist S. Andhra Pradesh Health Sector Reform: A Narrative Case Study. Hyderabad, India: ACCESS Health Initiative, 2009. http://www. rockefellerfoundation.org/uploads/files/f9850c94-5c05-4025- b47d-1b206cb95ccf-7.pdf (accessed 19 Jul 2011).